Indicators

Latest News about BHVN

Recent news which mentions BHVN

< Previous 1 2 3 4 5 6 Next >

2 Extraordinary Events Sent These 2 Stocks Soaring Tuesday

May 10, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

May 10, 2022

Mid-Day Market Update: U.S. Stocks Turn Lower; Biohaven Pharmaceutical Shares Jump

May 10, 2022

77 Stocks Moving In Tuesday's Mid-Day Session

May 10, 2022

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves

May 10, 2022

Recap: Biohaven Pharma Hldgs Q1 Earnings

May 10, 2022

Pfizer Acquires This Migraine Drug Maker For $11B: What Investors Need To Know

May 10, 2022

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

May 10, 2022

Here’s a list of 50 companies that are well-armed to beat back inflation

May 10, 2022

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis

April 27, 2022

European Commission Granted Marketing Authorization For Pfizer and Biohaven's VYDURA® (Rimegepant) For Migraine

April 27, 2022

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight

April 03, 2022

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates

April 01, 2022

Biohaven Pharmaceutical's Return On Capital Employed Insights

February 28, 2022

Biohaven Further Deepens Its Neurology Pipeline With Bristol Myers, Knopp Biosciences Deals

February 25, 2022

The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision

February 25, 2022

Biohaven Pharma: Q4 Earnings Insights

February 25, 2022

Earnings Scheduled For February 25, 2022

February 25, 2022

Biohaven Pharmaceutical's Earnings Outlook

February 24, 2022

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow

February 20, 2022

Biohaven/Pfizer Partnered Rimegepant Asia-Pacific Migraine Trial Meets Primary Endpoints

February 14, 2022

What to Expect From Biogen's $2.3 Billion Shopping Spree

February 12, 2022

New Psychedelics ETF Launches On NYSE Arca

February 02, 2022

Is This a Smart Deal for Pfizer?

January 29, 2022

Where Biohaven Pharma Hldgs Stands With Analysts

January 07, 2022

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales

January 06, 2022

Biohaven's Zavegepant Pain Spray Aces Late-Stage Migraine Trial

December 06, 2021

What 6 Analyst Ratings Have To Say About Biohaven Pharma Hldgs

November 10, 2021

75 Biggest Movers From Yesterday

November 10, 2021

58 Stocks Moving In Monday's Mid-Day Session

November 09, 2021

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.